Targeting NTCP for liver disease treatment: A promising strategy
Journal of Pharmaceutical Analysis · 2024-09 · 14 (9) · 100979
DOI: 10.1016/j.jpha.2024.100979 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-09. Verfasst von Xin Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, …. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The sodium taurocholate co-transporting polypeptide (NTCP), a bile acids transporter, has been identified as a new therapeutic target for the treatment of liver disease. This paper thoroughly investigates the function of NTCP for regulating bile acid regulation, its correlation with hepatitis B and D infections, and its association with various liver diseases. Additionally, in this review we examine recent breakthroughs in creating NTCP inhibitors and their prospective applications in liver disease treatment. While this review emphasizes the promising potential of targeting NTCP, it concurrently underscores the need for broader and more detailed research to fully understand the long-term implications and potential side effects associated with NTCP inhibition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
- Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
- College of Medicine, University of Electronic Science and Technology, Chengdu, 610072, China.
- Guanghan People's Hospital, Guanghan, Sichuan, 618300, China.
Zitieren
APA
Tan, X., Xiang, Y., Shi, J., Chen, L., & Yu, D. (2024). Targeting NTCP for liver disease treatment: A promising strategy. Journal of Pharmaceutical Analysis, 14(9), 100979. https://doi.org/10.1016/j.jpha.2024.100979
Vancouver
Tan X, Xiang Y, Shi J, Chen L, Yu D. Targeting NTCP for liver disease treatment: A promising strategy. Journal of Pharmaceutical Analysis. 2024;14(9):100979. doi:10.1016/j.jpha.2024.100979
BibTeX
@article{Tan2024,
author = {Tan, Xin and Xiang, Yu and Shi, Jianyou and Chen, Lu and Yu, Dongke},
title = {Targeting NTCP for liver disease treatment: A promising strategy},
journal = {Journal of Pharmaceutical Analysis},
year = {2024},
volume = {14},
number = {9},
pages = {100979},
doi = {10.1016/j.jpha.2024.100979}
}
EUVIMED